Top 10 Generic Antibiotic & Antimicrobial Drug Manufacturers in Japan

Robert Gultig

5 January 2026

Top 10 Generic Antibiotic & Antimicrobial Drug Manufacturers in Japan

User avatar placeholder
Written by Robert Gultig

5 January 2026

Introduction:

The generic antibiotic and antimicrobial drug market in Japan continues to be a significant player in the pharmaceutical industry, with a growing demand for these essential medications. In 2020, the market size for generic antibiotics and antimicrobials in Japan was estimated to be around $2.5 billion, with a steady increase in production volume to meet the healthcare needs of the population.

Top 10 Generic Antibiotic & Antimicrobial Drug Manufacturers in Japan:

1. Daiichi Sankyo Company, Limited
Daiichi Sankyo is a leading pharmaceutical company in Japan, with a strong presence in the generic antibiotic and antimicrobial drug market. The company has a production volume of over 100 million units annually, making it a key player in the industry.

2. Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical is another major player in the generic antibiotic and antimicrobial drug market in Japan. With a market share of 15%, Takeda has established itself as a reliable supplier of high-quality medications.

3. Astellas Pharma Inc.
Astellas Pharma is known for its innovative research and development in the pharmaceutical industry. The company’s generic antibiotic and antimicrobial drugs have a strong presence in the market, with exports to over 50 countries worldwide.

4. Eisai Co., Ltd.
Eisai Co., Ltd. is a leading Japanese pharmaceutical company with a focus on developing innovative medications. The company’s generic antibiotic and antimicrobial drugs have gained popularity for their effectiveness and affordability.

5. Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical is a well-known name in the pharmaceutical industry, with a wide range of medications including generic antibiotics and antimicrobials. The company’s commitment to quality and innovation has helped it secure a significant market share in Japan.

6. Shionogi & Co., Ltd.
Shionogi & Co., Ltd. is a pharmaceutical company with a long history of producing high-quality medications. The company’s generic antibiotic and antimicrobial drugs are widely used in hospitals and clinics across Japan.

7. Mitsubishi Tanabe Pharma Corporation
Mitsubishi Tanabe Pharma is a trusted name in the pharmaceutical industry, known for its commitment to research and development. The company’s generic antibiotic and antimicrobial drugs have seen a steady increase in demand, both domestically and internationally.

8. Kyowa Kirin Co., Ltd.
Kyowa Kirin is a pharmaceutical company with a focus on specialty medications, including generic antibiotics and antimicrobials. The company’s products are known for their efficacy and safety, making them a preferred choice among healthcare professionals.

9. Chugai Pharmaceutical Co., Ltd.
Chugai Pharmaceutical is a subsidiary of Roche Group, specializing in the development of innovative medications. The company’s generic antibiotic and antimicrobial drugs have gained popularity for their high quality and affordability.

10. Daiichi Sankyo Company, Limited
Daiichi Sankyo Company, Limited is a prominent player in the generic antibiotic and antimicrobial drug market in Japan, with a strong focus on research and development. The company’s products are widely used in hospitals and clinics across the country, contributing to its significant market share.

Insights:

The generic antibiotic and antimicrobial drug market in Japan is expected to continue growing in the coming years, driven by the increasing demand for these essential medications. With a growing aging population and rising healthcare costs, there is a greater need for affordable and effective generic medications. In 2021, the market size for generic antibiotics and antimicrobials in Japan is projected to reach $3 billion, with a steady increase in production volume to meet the growing demand. As more companies invest in research and development, we can expect to see innovative new medications entering the market, further driving growth in the industry.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →